Oral and perioral soft tissue lesions and oral functions in patients with dystrophic epidermolysis bullosa

Keywords: blister;, cicatrix;, epidermolysis bullosa dystrophica;, microstomia;, mouth;, preventive dentistry.

Abstract


Background/Aim. Dystrophic epidermolysis bullosa (DEB) is characterized by distinct systemic and skin changes, as well as numerous oral manifestations. The aim of the study was to examine oral and perioral soft tissues and oral functions in DEB patients by monitoring changes over a period of one year. Methods. Twenty-four patients (1 month to 36 years old) were clinically examined initially (T0), after 6 months (T6), and after 12 months (T12). Appearance and localization of perioral and oral bullae and scars, maximum mouth opening, reduced vestibule depth, absence of lingual papillae and palatal rugae, and restricted tongue movement due to scarring were monitored. The values of maximum mouth opening at the initial examination were compared to those measured in the healthy control group of the same age. The age of patients and differences between the dominant and recessive subtypes of DEB were analyzed. Results. The average maximum mouth opening was significantly lower in DEB patients compared to healthy individuals. Oral and perioral bullae and scars, microstomia, and reduced vestibule depth were very common, with no statistically significant difference among T0, T6, and T12. The prevalence of restricted tongue movement due to scarring and the absence of lingual papillae and palatal rugae increased significantly over one year. Patients with microstomia, vestibule depth, and restricted tongue movement due to scarring were significantly older than patients without these characteristics. Lingual papillae and palatal rugae were more frequently absent in recessive than dominant DEB. Conclusion. DEB causes significant changes in oral and perioral soft tissues and oral functions impairment.

References

Pfendner EG, Lucky AW. Dystrophic Epidermolysis Bullosa. 2006 Aug 21 [updated 2018 Sep 13]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020.

Scheidt L, Sanabe ME, Diniz MB. Oral manifestations and dental management of epidermolysis bullosa simplex. Int J Clin Pediatr Dent 2015; 8(3): 239‒41.

Fine JD, Bruckner-Tuderman L, Eady RA, Bauer EA, Bauer JW, Has C, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol 2014; 70(6): 1103‒26.

Intong LR, Murrell DF. Inherited epidermolysis bullosa: new diagnostic criteria and classification. Clin Dermatol 2012; 30(1): 70‒7.

Breitenbach J, Gruber C, Klausegger A, Trost A, Bogner B, Reitsamer H, et al. Pseudosyndactyly – an inflammatory and fibrotic wound healing disorder in recessive dystrophic epidermolysis bullosa. J Dtsch Dermatol Ges 2015; 13(12): 1257‒66.

Walker GD, Woody M, Orrin E, Mellerio JE, Levy ML. Epidermolysis bullosa with pyloric atresia and significant urologic involvement. Pediatr Dermatol 2017; 34(1): e61‒e4.

Fine JD, Hall M, Weiner M, Li KP, Suchindran C. The risk of cardiomyopathy in inherited epidermolysis bullosa. Br J Dermatol 2008; 159(3): 677-82.

Colomb V, Bourdon-Lannoy E, Lambe C, Sauvat F, Hadj Rabia S, Teillac D, et al. Nutritional outcome in children with severe generalized recessive dystrophic epidermolysis bullosa: a short- and long-term evaluation of gastrostomy and enteral feeding. Br J Dermatol 2012; 166(2): 354‒61.

Dammak A, Zribi J, Boudaya S, Mseddi M, Meziou TJ, Masmoudi A, et al. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases. Int J Dermatol 2009; 48(6): 588‒91.

Eswara U. Dystrophic epidermolysis bullosa in a child. Contemp Clin Dent 2012; 3(1): 90‒2.

Serrano-Martinez MC, Bagan JV, Silvestre FJ, Viguer MT. Oral lesions in recessive dystrophic epidermolysis bullosa. Oral Dis 2003; 9(5): 264‒8.

Azrak B, Kaevel K, Hofmann L, Gleissner C, Willershausen B. Dystrophic epidermolysis bullosa: oral findings and problems. Spec Care Dentist 2006; 26(3): 111‒5.

Kramer SM, Serrano MC, Zillmann G, Galvez P, Araya I, Yanine N, et al. Oral health care for patients with epidermolysis bullosa – best clinical practice guidelines. Int J Paediatr Dent 2012; 22(Suppl 1): 1‒35.

De Benedittis M, Petruzzi M, Favia G, Serpico R. Oro-dental manifestations in Hallopeau-Siemens-type recessive dystrophic epidermolysis bullosa. Clin Exp Dermatol 2004; 29(2): 128‒32.

Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol 2018; 125(6): 582‒90.

Stellingsma C, Dijkstra PU, Dijkstra J, Duipmans JC, Jonkman MF, Dekker R. Restrictions in oral functions caused by oral manifestations of epidermolysis bullosa. Eur J Dermatol 2011; 21(3): 405‒9.

Feijoo JF, Bugallo J, Limeres J, Penarrocha D, Penarrocha M, Diz P. Inherited epidermolysis bullosa: an update and suggested dental care considerations. J Am Dent Assoc 2011; 142(9): 1017‒25.

Leal SC, Lia EN, Amorim R, Dos Santos MV, de Araujo MC, de Medeiros RA, et al. Higher dental caries prevalence and its association with dietary habits and physical limitation in epidermolysis bullosa patients: a case control study. J Contemp Dent Pract 2016; 17(3): 211‒6.

World Health Organization. Oral health surveys: basic methods. 5th ed. Geneva, Switzerland: World Health Organization; 2013.

Wright JT, Fine JD, Johnson LB. Oral soft tissues in hereditary epidermolysis bullosa. Oral Surg Oral Med Oral Pathol 1991; 71(4): 440‒6.

Wright JT. Oral manifestations in the epidermolysis bullosa spectrum. Dermatol Clin 2010; 28(1): 159‒64.

Delebarre H, Chiaverini C, Vandersteen C, Savoldelli C. Orofacial management for epidermolysis bullosa during wisdom tooth removal surgery: a technical note. J Stomatol Oral Maxillofac Surg 2019; 120(5): 467‒70.

Mello BZ, Neto NL, Kobayashi TY, Mello MB, Ambrosio EC, Yaedu RY, et al. General anesthesia for dental care management of a patient with epidermolysis bullosa: 24-month follow-up. Spec Care Dentist 2016; 36(4): 237‒40.

Yoon RK, Ohkawa S. Management of a pediatric patient with epidermolysis bullosa receiving comprehensive dental treatment under general anesthesia. Pediatr Dent 2012; 34(3): 251‒3.

McPhie A, Merkel K, Lossius M, Giordano BP, Kelly MN. Newborn infant with epidermolysis bullosa and ankyloglossia. J Pediatr Health Care 2016; 30(4): 390‒5.

Messner AH, Lalakea ML. The effect of ankyloglossia on speech in children. Otolaryngol Head Neck Surg 2002; 127(6): 539‒45.

Wright JT. Comprehensive dental care and general anesthetic management of hereditary epidermolysis bullosa. A review of fourteen cases. Oral Surg Oral Med Oral Pathol 1990; 70(5): 573‒8.

Kummer TR, Nagano HC, Tavares SS, Santos BZ, Miranda C. Oral manifestations and challenges in dental treatment of epidermolysis bullosa dystrophica. J Dent Child (Chic) 2013; 80(2): 97‒100.

Lindemeyer R, Wadenya R, Maxwell L. Dental and anaesthetic management of children with dystrophic epidermolysis bullosa. Int J Paediatr Dent 2009; 19(2): 127‒34.

Oliveira TM, Sakai VT, Candido LA, Silva SM, Machado MA. Clinical management for epidermolysis bullosa dystrophica. J Appl Oral Sci 2008; 16(1): 81‒5.

Published
2022/05/20
Section
Original Paper